Bone Tumours, Osteosarcoma

Bone Tumours
Mechanisms of spread
• Local
• Haematogenous
• Lymphatic
• Intramedullary
• Others e.g. injections, transfer (iatrogenic)
Clinical Diagnosis of tumours
a) Age of patient;
• < 5yrs old - Malignant
• 5-30yrs old - Benign; Also Ewing's sarcoma &
Osteosarcoma
• 30-60yrs - Mixed - Chondrosarcoma,
Fibrosarcoma
• > 60yrs - Secondaries (malignant); Multiple
myeloma
• b) Symptoms;
• • Benign - No pain
• • Malignant - Vascular pain - Worse at night
& throbbing due to ischemia due to increased
blood
• demand; Also 2° to pressure effect on bone &
soft tissue
• c) Duration of symptoms;
• • 3 months - Malignant
• • 6 months - Borderline
• • 1 year - Benign
• d) Imaging;
• • Benign - well defined transitional zone with
regular/Scalloped margins e.g.
Osteochondroma which
• are mostly metaphyseal especially around the
knee & may be pediculated or sessile
• • Malignant - Diffuse transitional zone
• Enneking System of Classifying Musculoskeletal Tumours
• I - All low-grade sarcomas with <25% chance of metastasis e.g. 2°
chondrosarcoma, Parosteal
• osteosarcoma
• II - Histologically high-grade lesions with >25% chance of metastasis
e.g. osteosarcoma & fibrosarcoma
• III - Sarcomas which have metastasized
• +
• A - Intracompartmental e.g. A lesion contained in a single muscle
belly or a bone lesion that has not broken out
• into the surrounding soft tissue
• B - Extracompartmental e.g. A lesion in the popliteal space, axilla,
pelvis, or midportion of the hand or foot
Osteosarcoma
• Osteosarcoma is a high grade malignant tumour
arising within the bone &
• Spreading rapidly outwards to the periosteum &
surrounding soft tissues.
• Epidemiology
• Children > Adults - 5-19yrs; 22-26yrs - This has been
attributed to increased bone growth
• Adults - ≥60yrs - History of exposure to radiation when
young &/or bone infection
• M:F - 2:1
Pathogenesis
• The tumour is usually situated in the metaphysis of a

long bone, especially around the knee & at the proximal
end of the humerus, where it destroys & replaces
normal bone. Areas of bone loss & cavitation alternate
with dense patches of abnormal new bone. The tumour
extends within the medulla & across physeal plate. There
may be obvious spread into the soft tissues with
ossification at the periosteal margins & streaks of new
bone extending into the extra-osseous mass. The
tumour spreads mostly haematogenously >
intramedullary > local spread. Rarely lymphatic.
Classification
a) Primary;
• Central (classical)
* High grade - Distal femur, proximal tibia & proximal
humerus
• Juxtacortical;
* Low grade (Parosteal) - Distal femur
* Intermediate grade (Periosteal) - Shaft of long bones
* High grade (surface sarcoma) - Shaft of long bones
• Haemorrhagic or Telangiectatic;
* High grade - Epiphysis
b) Secondary (arise secondary to):
• Paget's disease
• Radiation
• Fibrous dysplasia
Clinical presentation
• Pain - constant, worse at night & gradually
increases in severity
• Swelling
• Local tenderness
** Pathological fracture is rare
Investigations
X-Ray;
i) Hazy osteolytic lesions alternating with unusually dense
osteoblastic areas
ii) The endosteal margin is poorly defined
iii) The cortex is breached & the tumour extends into the
adjacent tissues; when this happens, streaks of new
bone appear radiating outwards from the cortex - Sunburst
effect
iv) Where the tumour emerges from the cortex, reactive new
bone forms at the angles of periosteal elevation -
Codman's triangle
Blood;
- FHG + ESR
- ↑ ALP + LDH
• CT for staging - Pulmonary CT is a much more sensitive detector of lung
metastases which are present in about 10% of patients at presentation.
• Liver ultrasound
• Scintigraphy using Methyldiphosphonate PC99 (MDP)- For skip lesions
• Biopsy;
* FNAC
* Incisional biopsy - All layers from skin to bone
* Excisional biopsy - Wide margin (at least 2mm)
• MRI is NOT very useful
differentials
• Stress fracture
• Infection - Acute osteomyelitis
• Post-traumatic swelling
• 'Cystic' lesions
• Other tumours
Management
a) Supportive
b) Specific
• Multi-agent neo-adjuvant chemotherapy is given for 8-12wks;
* Eliminates micrometastasis
* Reduces size of tumour reactive zone
* Causes tumour necrosis
Then provided the tumour is resectable & there are no skip lesions, a
wide resection is carried out.
• The segment of bone is replaced with either a large bone graft or a
custom made implant; in some cases, amputation may be more
appropriate.
The tumour responds well to Methotrexate, Adriamycin, Cisplatin,
Ifafosphamide
• Prognosis
Long-term survival after wide resection &
chemotherapy - 50-60% if treated early &
<10% if late presentation.

Bone Tumours, Osteosarcoma

Uploaded by

Copyright:

Available Formats

Bone Tumours, Osteosarcoma

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Bone Tumours, Osteosarcoma

Uploaded by

Copyright:

Available Formats

Bone Tumours

• The tumour is usually situated in the metaphysis of a

You might also like